Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €130.60 | €140.60 | 7.660% |
| Merit Medical Systems | 17 | 0 | 4 | 0 | €74.00 | €86.90 | 17.428% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €68.00 | €106.18 | 56.146% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.75 | €17.78 | 103.191% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.40 | €421.61 | 16.017% |
| United Therapeutics | 18 | 0 | 3 | 0 | €254.90 | €288.66 | 13.245% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.32 | €26.01 | 34.609% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.20 | €84.74 | 121.843% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.79 | €52.03 | 128.280% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €76.50 | €75.94 | -0.737% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.60 | €236.30 | 71.728% |
| Halozyme Therapeutics Inc. | 14 | 0 | 2 | 0 | €41.45 | €50.33 | 21.430% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €167.85 | €215.54 | 28.411% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €110.00 | €116.99 | 6.357% |
| PTC Therapeutics Inc. | 14 | 6 | 2 | 1 | €31.20 | €42.12 | 34.986% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.40 | €38.99 | 24.168% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €22.60 | €32.58 | 44.154% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.80 | €184.76 | 18.588% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €106.75 | €147.62 | 38.282% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €94.88 | - | - |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €85.50 | €92.26 | 7.906% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €23.00 | €24.18 | 5.134% |
| Bruker Corp. | 8 | 1 | 1 | 0 | €70.20 | €84.02 | 19.692% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €95.00 | €124.85 | 31.419% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €21.22 | - | - |